Robert J. Weiland - Net Worth and Insider Trading
Robert J. Weiland Net Worth
The estimated net worth of Robert J. Weiland is at least $124,860 dollars as of 2025-03-26. Robert J. Weiland is the Chief Commercial Officer of Pacira BioSciences Inc and owns about 5,088 shares of Pacira BioSciences Inc (PCRX) stock worth over $124,860. Details can be seen in Robert J. Weiland's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert J. Weiland has not made any transactions after 2018-06-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert J. Weiland
Robert J. Weiland Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert J. Weiland owns 2 companies in total, including CymaBay Therapeutics Inc (CBAY) , and Pacira BioSciences Inc (PCRX) .
Click here to see the complete history of Robert J. Weiland’s form 4 insider trades.
Insider Ownership Summary of Robert J. Weiland
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CBAY | CymaBay Therapeutics Inc | 2017-06-28 | director |
| PCRX | Pacira BioSciences Inc | 2018-06-04 | Chief Commercial Officer |
Robert J. Weiland Latest Holdings Summary
Robert J. Weiland currently owns a total of 1 stock. Robert J. Weiland owns 5,088 shares of Pacira BioSciences Inc (PCRX) as of June 4, 2018, with a value of $124,860.
Latest Holdings of Robert J. Weiland
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PCRX | Pacira BioSciences Inc | 2018-06-04 | 5,088 | 24.54 | 124,860 |
Holding Weightings of Robert J. Weiland
Robert J. Weiland Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert J. Weiland has made a total of 0 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years. The most-recent trade in Pacira BioSciences Inc is the sale of 373 shares on June 4, 2018, which brought Robert J. Weiland around $12,317.
Insider Trading History of Robert J. Weiland
- 1
Robert J. Weiland Trading Performance
Robert J. Weiland Ownership Network
Ownership Network List of Robert J. Weiland
Ownership Network Relation of Robert J. Weiland
Robert J. Weiland Owned Company Details
What does CymaBay Therapeutics Inc do?
Who are the key executives at CymaBay Therapeutics Inc?
Robert J. Weiland is the director of CymaBay Therapeutics Inc. Other key executives at CymaBay Therapeutics Inc include Chief Scientific Officer Charles Mcwherter , Vice President & Finance Daniel Menold , and General Counsel Paul T Quinlan .
CymaBay Therapeutics Inc (CBAY) Insider Trades Summary
Over the past 18 months, Robert J. Weiland made no insider transaction in CymaBay Therapeutics Inc (CBAY). Other recent insider transactions involving CymaBay Therapeutics Inc (CBAY) include a net sale of 62,820 shares made by Charles Mcwherter , a net sale of 20,000 shares made by Paul T Quinlan , and a net sale of 19,000 shares made by Janet Dorling .
In summary, during the past 3 months, insiders sold 0 shares of CymaBay Therapeutics Inc (CBAY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 278,962 shares of CymaBay Therapeutics Inc (CBAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 278,962 shares.
CymaBay Therapeutics Inc (CBAY)'s detailed insider trading history can be found in Insider Trading Tracker table.
CymaBay Therapeutics Inc Insider Transactions
Robert J. Weiland Mailing Address
Above is the net worth, insider trading, and ownership report for Robert J. Weiland. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Robert J. Weiland's mailing address is: Newark Ca 94560.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
